China Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) tourism market is expected to surpass US$ 28 Billion by 2025.

China Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) tourism market is expected to surpass US$ 28 Billion by 2025.

“China Outbound MICE Tourism Market Report, Analysis and Forecast to 2025” offers the most up–to–date industry data on the actual market situation and future outlook for China outbound MICE tourism market. The report uses data and analysis to discuss potential lucrative opportunities and future trends related to China outbound MICE travelers flow, revenue and main destination markets. The report provides clear insight into current and future tourism developments of the China outbound MICE tourism market. Furthermore, this report uses country focused analysis to explore China outbound MICE tourism market.

A detailed country-wise analysis of the market is provided, covering a total of 21 countries. The research study limelight growth drivers and investigates market inhibitors of China outbound MICE tourism market.

The countries included in this report are Hong Kong, Thailand, South Korea, Macau, India, Singapore, Malaysia, Japan, United States, Philippines, Vietnam, Cambodia, Indonesia, Germany, France, Italy, Switzerland, Russia, United Kingdom, Spain, Australia and Other Countries

Further key findings from the report suggest:

•China is one of the fastest growing outbound MICE tourism markets

•Chinese MICE travelers made nearly 5 million trips in 2017.

•United States and Hong Kong generates the highest revenue in the market

•Japan is anticipated to register fastest growth rate over the forecast period

The Latest Industry Data Included in this Report:

•Market Size & Analysis: China Outbound Travelers Visitation & Spending (2013 – 2025)

•China Outbound Travelers Visitation & Forecast (2013 – 2025)

•China Outbound Travelers Spending & Forecast (2013 – 2025)

•Market Size & Analysis: China Outbound MICE Travelers Visitation & Spending (2013 – 2025)

•China Outbound MICE Travelers Visitation & Forecast (2013 – 2025)

•China Outbound MICE Travelers Spending & Forecast (2013 – 2025)

•China Outbound MICE Travelers Visitation & Spending Share & Y-o-Y Growth (%) (2013 – 2025)

•China MICE Travelers Visitation to Major 21 Countries & Forecast (2013 – 2025)

•China MICE Travelers Spending to Major 21 Countries & Forecast (2013 – 2025)

•Identification of Key Market Drivers and Inhibitors of the China Outbound MICE Tourism Market

Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. 

 

Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation

 

• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024

 

• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season

 

• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024

 

• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Key Topics Covered in the Report

• Market Overview: United States Flu Vaccine Market (2010 –  2024)

• United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)

• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification

• Reimbursement & Regulatory System in the US Flu Vaccine Market

• Mergers, Acquisitions, Key Agreements & Collaborations

• Promising Flu Vaccine in Clinical Development

• Flu Vaccine Clinical Trial Insights by Phase, Company & Country

• Key Drivers and Inhibitors of the US Flu Vaccine Market

• Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:

• Fluzone High–Dose

• Fluzone Quadrivalent

• Intradermal (ID) Trivalent

•Vaxigrip

• Fluarix Quadrivalent

• Flulaval Quadrivalent

• Flucelvax Quadrivalent

• Afluria Quadrivalent

• Agrippal

• Fluad

• Fluvirin

• Fluvax

Key Companies Covered in This Report:

• Seqirus

• Sanofi Pasteur

• GlaxoSmithKline(GSK)

Read More @ http://www.dpiresearch.com/report-details.php?P_ID=110

United States and Japan Proton Therapy Market Analysis 2012 to 2017 and Forecast 2018 to 2025

“United States and Japan Proton Therapy Market Analysis 2012 to 2017 and Forecast 2018 to 2025” presents an in-depth assessment of the proton therapymarket dynamics,opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for proton therapy in United States and Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025.

A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies. The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US and Japan proton therapy centers. The report also includes assessment of US and Japan reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the US and Japan proton therapy market.

The report concludes with the profiles of major players in the US and Japan proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies, recent development of the proton therapy market.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Hitachi, Optivus, Ion Beam Applications(IBA), Varian Medical Systems, Mevion Medical Systems, Mitsubishi Electric, Sumitomo Heavy Industries Ltd. 

Key Findings:

• United States proton therapy marketwill exhibit growth by a CAGR of over 15% up to 2025

• The potential United States and Japan proton therapy market is set to cross USD 10 Billion by 2025

• In 2017, IBA accounted highest number of proton therapy centers in United States

• Hitachi has the second highest number of treatment rooms in United States and Japan

• Hitachi and Mitsubishi Electric Merged Proton Therapy System Business

This independent 160-page report has been analysed from 15 viewpoints: 

• United States and Japan Proton Therapy Market Size & Analysis(2012 – 2025)

• United States and Japan Proton Therapy Market Opportunity Assessment(2012 – 2025)

• United States and Japan Number of Treatment Rooms and Forecast (2012 – 2025)

• United States and Japan Proton Therapy Center (Installed Base) and Treatment

   Room Market Share: By Company

• United States and Japan Proton Therapy Center Infrastructure Analysis: Treatment

   Rooms & Proton Therapy Accelerator

• Major Deals in Proton Therapy Market

• United States and Japan Number of Patients Treated at Proton Therapy Center

• United States and Japan Proton Therapy Reimbursement Scenario

• Proton Therapy Current Applications

• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy

• Proton Therapy Competitive Analysis: By Company

• Proton Therapy Center Component Analysis

• Proton Therapy Clinical Trail Insight by Phase, Institute & Country

• Key Market Drivers and Inhibitors

• Major Companies Analysis

Read More and Order @ http://www.dpiresearch.com/report-details.php?P_ID=129

日本のプロトン療法市場調査レポート2018

日本のプロトン療法市場調査レポート2018

Globe Market Reports - In Depth Market Insights

「日本陽子治療市場調査レポート2018」は、市場動向、競争環境、主要動向などを調査しています。報告書は、実際のおよび潜在的な市場状況に関する最新の業界データ、および日本におけるプロトン療法の将来の展望を提供している。調査には、2012年から2017年の歴史的データと2025年までの予測が含まれています。

ブラウズ全レポート@ http://www.dpiresearch.com/report-details.php?P_ID=126

長期的な成長予測： ・日立と三菱電機、プロトン療法システム事業の統合に合意•日本は、陽子線治療業界において最も魅力的な市場となることが予想されます。•潜在的な日本の陽子線治療市場は、2025年までに30億米ドル以上に達する可能性がある•三菱電機は、日本の陽子線治療分野の技術リーダーです。•日立は、治療室セグメントで2番目に高いシェアを占めています。

このレポートには、現在の業界状況、市場需要、市場規模、量、収益に関する事実を明らかにするとともに、2025年までの予測を提供する詳細な分析が含まれています。日本の陽子線治療センター（設置ベース）会社別治療室また、陽子線治療の現状と応用について、陽子治療の賛否両論と8社の競争分析を中心に比較分析を行っています。 この報告書はさらに、治療室の数、現在のプロトン療法センターおよび今後のプロトン療法センターの数を明らかにする。また、この報告書は、2008年から2016年までの日本の陽子線治療センターで治療された患者の数についての重要な洞察も提供している。

このレポートには、日本の償還シナリオの評価、陽子線治療の臨床試験、陽子線治療センターの成分分析の明確な見解も含まれています。ベンチャーキャピタル投資、コラボレーション、パートナーシップ、ライセンス供与および開発契約の主要動向を詳細に分析します。また、日本の陽子線療法市場の成長促進要因と阻害剤についての詳細な解説も行っています。 報告書は、日本の陽子線治療市場における主要な選手のプロフィールで終わります。主要市場の選手は、会社概要、製品ポートフォリオ、企業が開発した日本の陽子線治療センター、陽子線治療市場の最近の発展と傾向などのさまざまなパラメータで評価されます。

製品、サービス、および継続的な製品開発のためにこの市場を支配する主要企業は以下のとおりです。 三菱電機、日立、住友重機械、イオンビーム応用（IBA）

このレポートに含まれる最新の業界データ：

• プロトン療法現在のアプリケーション
• 陽子線治療、放射線療法、および炭素イオン療法の長所と短所
• 陽子線治療競合分析：会社別
• 市場規模と分析：日本の陽子線治療（2012年〜2025年）
• 市場機会評価：日本の陽子線治療（2012年〜2025年）
• 日本の治療室数および予測（2012年〜2025年）
• 日本陽子治療センター（設置基地）と治療室市場    シェア：会社別
• 日本陽子治療センターインフラ分析：トリートメントルーム    ＆陽子線治療アクセラレータ
• 日本陽子治療センターで治療された患者の数（2008年〜2016年）
• 日本の陽子線療法償還シナリオ •プロトン療法センターの成分分析
• フェーズ、研究所およびカントリーによる陽子線治療臨床トレイルインサイト
• 陽子治療市場 – 主要取引
• 日本の陽子線治療市場の主要な市場促進要因と阻害剤 主要企業分析

View original post

Japan is anticipated to be the most attractive market in the proton therapy industry.

Japan is anticipated to be the most attractive market in the proton therapy industry.

Globe Market Reports - In Depth Market Insights

The report titled “Japan Proton Therapy Market Research Report 2018” examines the market dynamics, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation, and future outlook for proton therapy in Japan. The research includes historic data from 2012 to 2017 and forecasts until 2025.

Long–term Growth Projection:

• Hitachi and Mitsubishi Electric Agree to Integrate Proton Therapy System Business

• Japan is anticipated to be the most attractive market in the proton therapy industry.

• The potential Japan proton therapy market is likely to reach more than USD 3 Billion by 2025

• Mitsubishi Electric is a technology leader in the field of proton therapy in Japan.

• Hitachi has the second highest share in the treatment rooms segment.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size…

View original post 392 more words